New Data from Corvus Phase 1 Study of CPI-006 Continues to Support its Potential as a Treatment for COVID-19

Ads

You May Also Like

TESARO Joins Healthcare Businesswomen’s Association as Corporate Partner

WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

Sandoz Canada Launches a New Concentration of T/CLorazepam Injection USP

Lire la version française BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada ...